The Widetex Biotechnology Department was established in 1998, and since then it has been working hard to improve biotechnology foundry and process development technology. Has a wealth of bacterial fermentation experience and protein purification technology. Through the cooperation with other biotechnology company alliances and academic research units, a platform for mass production of genetically modified biotechnology products will be constructed. The use of rapid and large-scale production of bacteria to achieve the goal of mass production of genetically recombined products, to achieve the ideal of saving time, reducing manpower and reducing costs.

At present, the product range is wide, including antibiotic synthesis intermediates, genetically recombinant proteins/enzymes, biomaterials and other special biotechnology products.

If you still have other market potential products that need to scale up the mass production scale, you are welcome to contact us to further discuss ODM/OEM cooperation matters, we will be happy to provide you with services.